MARK1, active

N-terminal 6His-tagged recombinant, human MARK1 amino acids 2-end.

Catalog #: 14-651

$399.00$2,989.00


Inquire
Biological Information
Background Information:
MARK (MAP/microtubule affinity-regulating kinase) phosphorylates the microtubule-associated proteins tau, MAP2, and MAP4 on their microtubule-binding domain, causing their dissociation from microtubules and increased microtubule dynamics. Overexpression of MARK1 or MARK2 in cells leads to hyperphosphorylation of MAPs and to disruption of the microtubule array, resulting in morphological changes and cell death. GenBank AF154845. The recombinant protein contains the amino acid substitutions V16E and T20S with reference to AF154845. These mutations are reported in GenBank NM_018650, AK098103 and BC068608.
Target Class:
Kinase
Accession Number:
NM_018650.2
Target Name:
MARK1
Target Aliases:
MARK1, KIAA1477, MGC126512, MGC126513, MARK
Target Species:
Human
Usage
Product Type:
Enzymes
Application:
Drug Discovery & Development
Storage Conditions:
6 months at -70°C
Usage Disclaimer:
These products may be covered by issued US and/or foreign patents, patent application and subject to Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information.

Datasheets

14-651x Datasheet

View Document